enomyc supports M&A Deal: Multinational AI Alliance Formed to Combat Online Hate
28.8.2024 08:58:41 CEST | news aktuell GmbH | Press release
Paris / Hamburg, August 27th 2024 – With the acquisition of the Spanish AI specialist Insikt AI by the British company Logically, the M&A experts at the consulting firm enomyc have successfully completed another international transaction. enomyc's Paris office, which led the deal with support from German colleagues, was exclusively commissioned by Insikt AI to find a strategic partner. The acquisition creates a new multinational player in the fight against online hate.

Logically uses artificial intelligence (AI) to combat the damage caused by misleading and fraudulent online content. The Barcelona-based Insikt Intelligence operates in the same field, also with the support of AI.
“We thank the enomyc team, led by French Managing Partner Ian Kayanakis, for guiding us so successfully through this sales process,” says Jennifer Woodard, founder and CEO of Insikt. “With the acquisition, Logically strengthens its position as a leading company in using cutting-edge AI research to combat harmful content of all kinds.” Woodard, who will assume the role of Vice President of Artificial Intelligence at Logically, is recognized as an expert in AI applications for counter-terrorism. She advises organizations such as the UN and the European Commission on balancing the use of AI to combat online harms with ethical considerations.
AI-Powered Fight Against Online Hate and Threats
“The acquisition is a crucial step towards robust protection against increasingly sophisticated attackers, providing customers with new, advanced tools to protect freedom of speech and prevent the impact of harmful online content,” said Lyric Jain, founder and CEO of Logically. The company is headquartered in Brighouse, UK. Through the acquisition, Insikt’s technology will be integrated into Logically Intelligence®, Logically's leading intelligence platform. Customers will gain access to the most advanced methods and innovative developments based on AI research. This will enhance their ability to combat a broader portfolio of online threats, including terrorism and extremism, areas where INSIKT possesses outstanding capabilities.
Founded in 2016, Insikt empowers governments, private companies, and intelligence agencies to detect problems early and predict and mitigate the spread of harmful content with its technology. Awarded four Excellence Seals by the European Commission, Insikt has developed domain-specific machine learning (ML) models to uncover trends, threats, and anomalous patterns in large volumes of online data. The company is known in professional circles for its advanced Social Network Analysis (SNA) capabilities, which allow clients to uncover hidden connections and networks by analyzing relationships critical to online intelligence operations.
Contacts
Cathleen MöbiusHead of Marketing
Neuer Wall 57
20354 Hamburg
Images

About enomyc
enomyc is a Europe-wide consulting firm for medium-sized businesses and was founded in 2003 with a clear mission: to promote crisis-proof, sustainable, and high-performing growth of companies in the digital age. Today, enomyc is one of the leading consulting firms for the mid-market, with offices in Hamburg, Berlin, Frankfurt am Main, Cologne, Stuttgart, Munich, and Paris.
Since its founding in 2003, enomyc has supported medium and large enterprises through strategic consulting, digital transformation, and innovative growth strategies. enomyc has been recognized as "Best Consultants" by brand eins eleven times in a row (since 2014), received the TOP CONSULTANT Award eight times (since 2017), and was honored by WirtschaftsWoche in 2020 as one of Germany's best consulting firms.
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
FEV collaborates with Microsoft on efficient AI model approach for in car applications built on NVIDIA9.7.2026 11:05:00 CEST | Press release
Aachen – FEV is collaborating with Microsoft to integrate powerful, in-vehicle Generative AI capabilities built on NVIDIA GPU-accelerated compute and AI model microservices. The cooperation aims to enable multimodal voice, text, and gesture interactions directly in the vehicle – independent of a permanent Internet connection.
Acrobat Studio og Acrobat KI-assistent: den nye generasjonen KI-støttet produktivitet – nå også på norsk8.7.2026 15:08:48 CEST | Press release
SAN JOSE, Calif. - 8. juli 2026 - Adobe utvider tilgjengeligheten til Acrobat Studio og Acrobat KI-assistenten i Norge. Nå er de KI-støttede funksjonene for produktivitet og kreavtivitet også tilgjengelige på norsk, og kan dermed brukes av brukere på lokalt språk. Acrobat Studio kombinerer Adobe Acrobat Pro, Adobe Express Premium og smarte KI-assistenter. Acrobat KI-assistent er også tilgjengelig som et separat tillegg for alle Adobe Acrobat-produkter (Acrobat Reader, Acrobat Standard og Acrobat Pro) – et fleksibelt alternativ for alle som ønsker å bruke KI-støttede funksjoner kun når de arbeider med dokumenter. Begge disse tilbudene gjør det mulig for brukere å raskere samle inn informasjon i PDF-er og Office-dokumenter, opprette innhold og effektivisere arbeidsflyten. Acrobat Studio og Acrobat KI-assistenten markerer et viktig trinn i utviklingen av PDF-filen, som har blitt standarden for viktige dokumenter siden den ble lansert av Adobe i 1993. Acrobat utvikler seg fra et ledende pr
Grünenthal receives FDA Orphan Drug and Rare Pediatric Disease Designations for Tegacorat for the Treatment of Duchenne Muscular Dystrophy8.7.2026 10:37:04 CEST | Press release
Aachen, 08 July 2026 – Grünenthal announced today that its investigational compound tegacorat (GRM-01) received Orphan Drug and Rare Pediatric Disease Designations from the US Food and Drug Administration (FDA) for the treatment of Duchenne muscular dystrophy (DMD).
Grünenthal successfully completes Phase I trial with Nociceptin Receptor (NOP) Agonist29.6.2026 12:28:23 CEST | Press release
The investigational compound has a unique mechanism of action and the potential to become a first-in-class therapy option for the treatment of acute and chronic pain. In a Phase I trial, the investigational compound was demonstrated to be safe and well tolerated. A Phase II trial will commence later this year.
FRITZ: YouGov survey in 14 countries: Trust in router manufacturers from different regions European consumers mistrust Chinese routers29.6.2026 10:00:00 CEST | Press release
More than half of consumers in Norway mistrust routers from Chinese manufacturers (59%) Many mistrust devices made in the USA European routers enjoy a high level of trust across Europe (60%) For half of Europeans (55%), the ‘Made in Europe’ label important to when making a purchase
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom